Diovan References
Effect of valsartan on angiotensin II- and vasopressin-degrading activities in the kidney of normotensive and hypertensive rats.
Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure.
Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury.
Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice.
Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery.
Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
Myocardial bradykinin following acute angiotensin-converting enzyme inhibition, AT1 receptor blockade, or combined inhibition in congestive heart failure.
Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan.
Improving outcomes in congestive heart failure: Val-HeFT. Valsartan in Heart Failure Trial.
research_abstresearch_abst24-hour arterial hypertension profile and heart rhythm variability in patients with arterial hypertension and NIDDM
Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta.
Biphasic regulation of Na+-HCO3- cotransporter by angiotensin II type 1A receptor.
Effects of angiotensin type-I receptor blockade on pericardial fibrosis.
Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries.
Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
The effect of inhibition of renin-angiotensin system by valsartan during hypovolemic shock and low flow sigmoideal ischaemia in pigs.
Aminopeptidase activity in renovascular hypertension.
Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats.
research_abstCardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Angiotensin receptor subtypes in thin and muscular juxtamedullary efferent arterioles of rat kidney.
Enhanced angiotensin-mediated responses in the nucleus tractus solitarii of spontaneously hypertensive rats.
Valsartan. Just a second-line antihypertensive drug.
Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.
Role of superoxide in modulating the renal effects of angiotensin II.
ACE inhibitors and/or sartans in heart failure: is there a difference?
Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor.
Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
Binding of valsartan to mammalian angiotensin AT1 receptors.
Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.
Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose tolerance.
Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Secreted protein acidic and rich in cysteine expression after subtotal nephrectomy and blockade of the renin-angiotensin system.
Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis.
Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system.
Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells.
The effect of age on the pharmacokinetics of valsartan.
Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists.
Design and synthesis of nonpeptide angiotensin II receptor antagonists featuring acyclic imidazole-mimicking structural units.
research_abstComparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
research_abstAngiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.
Effects of combined angiotensin II and endothelin receptor blockade with developing heart failure: effects on left ventricular performance.
Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.
Salt sensitivity in genetically hypertensive rats of the Lyon strain.
Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet.
Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and LC.
Alterations of load-induced p38 MAP kinase activation in failing rat hearts.
Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy.
Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis
Online Pharmacies ||
Buy Antibiotics ||
Dream Pharmaceuticals Rx: Prescription Drugs Online ||
Buy Xenical Online ||
Diovan references ||
Online Pharmacy